What is Clear Cell Carcinoma of the Cervix?

Clear cell carcinoma of the uterine cervix is a rare and extremely invasive form of adenocarcinoma, which makes up 4% of all adenocarcinomas in the cervix. Historically, this condition has been tied to exposure to a drug called diethylstilbestrol (DES) before birth. However, there have been instances of clear cell adenocarcinoma in adult women and children who have not been exposed to DES. Importantly, there’s a higher rate of this condition entering a severe, late stage (stage III and IV) in children compared to adults where it is diagnosed. Symptoms often include abnormal vaginal bleeding (before first period, between periods, after sex, after menopause), unusual vaginal discharge, abdominal pain, or swelling in the lower extremities.

The diagnosis of this condition is primarily determined through a detailed examination of tissue samples collected via biopsy. Under the microscope, the carcinoma is mostly made up of clear or ‘hobnail’ cells, with a mixed structure including solid areas and areas resembling tubes or small cysts. These areas are mostly formed of cell groups with clear, pinkish cellular material and highly pigmented cell centers. Treatment depends on the stage at diagnosis and the patient’s preference to maintain fertility; options can include a mix of surgery, radiation, and chemotherapy.

What Causes Clear Cell Carcinoma of the Cervix?

Clear cell carcinoma of the cervix has traditionally been linked with exposure in the womb to a synthetic hormone known as DES. Despite this, cases can still occur without any DES exposure. Studies suggest that this in-womb exposure could affect certain genes which spikes cell growth or reduces the natural cell death process, which may lead to unrestricted cell growth and potential for cancer. It can also overstimulate the expression of certain growth factor genes. Additionally, genes responsive to estrogen like the lactoferrin gene can be activated by DES exposure.

Latest studies show that HPV (Human Papillomavirus) likely doesn’t contribute to the development of clear cell carcinoma of the cervix, which makes it unique among most other types of cervical cancer. Cervical endometriosis may lead to clear cell carcinoma of the cervix in women who haven’t been exposed to DES, due to a known link between endometriosis and clear cell carcinoma at other sites. However, the exact cause and development process of these tumors is not fully understood. There’s no concrete precursor lesion identified though some reports suggest that such cancers may develop from cervical endometriosis or tubo-endometrioid metaplasia.

Risk Factors and Frequency for Clear Cell Carcinoma of the Cervix

Clear cell carcinoma, a type of cancer found in the cervix, is the second most common kind that is not caused by HPV and makes up about 3% of all cases. It’s most common in two age groups: young adults around 26 years old (ranges from 17 to 37) and older adults around 71 (ranges from 44 to 88). Interestingly, patients who have been exposed to a drug called DES tend to be younger, with the peak age being 19.

  • Clear cell carcinoma is a cervical cancer and the second most common type not caused by HPV.
  • It accounts for about 3% of all cervical cancer cases.
  • The disease tends to appear most frequently in people around 26 years old (but can be from 17 to 37 years old) and 71 years old (but can be from 44 to 88 years old).
  • Patients exposed to the drug DES often get this type of cancer when they are younger, typically around 19 years old.

Signs and Symptoms of Clear Cell Carcinoma of the Cervix

Clear cell carcinoma of the uterine cervix is a condition that often shows up as abnormal vaginal bleeding. This bleeding can be after sexual intercourse or between periods and tends not to respond well to hormonal treatments. A physical examination may reveal a cervical abnormality, often described as a ‘fullness’ of the cervix. However, the tumour is usually not felt during a rectal examination.

Testing for Clear Cell Carcinoma of the Cervix

Imaging methods like magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT), and cytology are often used in the detection and assessment of pre-cancerous conditions like clear cell carcinoma of the cervix. These techniques help doctors plan treatments, forecast how the condition could progress, and make surgical decisions.

MRI scans are typically used for multiple tasks: determining the stage of the tumor, gauging the effectiveness of treatments, detecting whether the tumor has come back, and spotting any potential complications.

Another imaging method, using fluorodesoxyglucose and positron emission tomography with computed tomography (F-18 FDG PET/CT), can be useful in examining cases of clear cell carcinoma of the cervix that have spread to the lymph nodes in the pelvic cavity and the space behind the abdomen (also known as the retroperitoneum).

On the other hand, cytology, or the study of cells, may not be as effective for diagnosing cancers of the cervix such as adenocarcinomas. Researchers found that in a sample of 31 patients with cervical clear cell carcinoma, only 6 (or about 18%) showed abnormalities on their Pap test, suggesting that cytology wasn’t very helpful in detecting this type of cancer.

Treatment Options for Clear Cell Carcinoma of the Cervix

The treatment for clear cell carcinoma, a type of cancer, shares similarities with how cervical cancer is treated. Because of this, the patient’s outcome largely depends on the stage of the disease. However, it’s less clear how much risk comes with this specific type of cancer.

A common surgical treatment for early-stage cervical carcinoma, stages IB or IIA, is a radical hysterectomy and a pelvic lymphadenectomy. This treatment can result in the patient being unable to have children. For stages IIB and IIIB, the go-to treatment is external beam radiotherapy.

It’s important to mention that the findings from the clinic and the lab, as well as the prognosis of patients with clear cell carcinoma stages IB–IIB who weren’t exposed to a particular drug (DES) while in the womb, are alike to those of patients with other types of cancer, such as squamous cell carcinomas and non-clear cell adenocarcinomas.

Interestingly, a recent study compared two treatment options for stage IB1 cervical carcinoma in young women who wish to maintain their fertility. The study found no significant differences in survival rates between fertility-preserving radical trachelectomy and radical hysterectomy, indicating that the fertility-preserving surgery is a safe choice for early-stage cancer.

When a doctor is examining a patient for symptoms that could indicate a cervical cancer type known as clear cell carcinoma, it’s important to check for other potential conditions that can show similar symptoms. These might be other types of cervical cancer such as squamous cell carcinoma and other cervical adenocarcinomas. They could also be less severe conditions like benign (not cancerous) cervical lesions or infections like cervicitis (inflammation of the cervix). Correctly identifying the condition is crucial to provide the right treatment. The list of conditions the doctor may consider includes:

  • Metastatic clear cell carcinoma (Cancer that has originated from other body parts)
  • Arias-Stella reaction (A condition often related to pregnancy)
  • Adenosis (A benign condition marked by an excess of glandular tissue)
  • Endometrioid adenocarcinomas (a type of uterine cancer) showing certain specific changes
  • Gastric-type of endocervical adenocarcinoma (a rare type of cervical cancer)
  • Cervical yolk sac tumors (a rare type of ovarian germ cell tumor)
  • Primary cervical alveolar soft part sarcomas (a rare type of soft tissue tumor)
  • Benign cervical lesions (non-cancerous cervical conditions)
  • Cervicitis (inflammation of the cervix)

What to expect with Clear Cell Carcinoma of the Cervix

Research regarding the outcome of cervical clear cell carcinoma is inconsistent. Some studies show outcomes equivalent to typical cervical adenocarcinoma, whereas others suggest a much more aggressive course of disease.

A prognosis for this condition depends on several factors:

* The FIGO stage of the cancer
* The size of the tumor
* The growth pattern of the cancer cells
* Irregularities in the nucleus of the cells (nuclear atypia)
* Mitotic activity, which reflects how rapidly the cancer cells are dividing
* How deep into the stroma (connective tissue that supports organs) the cancer has invaded

The most important factors affecting the likelihood of disease progression and overall survival are the FIGO stage and the status of the pelvic nodes.

There’s no existing data comparing the prognosis between clear cell carcinoma and other subtypes such as gastric type endocervical adenocarcinoma and HPV-associated cervical adenocarcinoma. While there are case reports suggesting clear cell carcinomas have a worse prognosis than HPV-associated cervical adenocarcinoma, two large-scale studies did not find a connection, possibly due to these studies being carried out before a system to classify the causes of these cancers was introduced.

In another bigger study, when comparing treatment outcomes, clear cell carcinomas fared worse than HPV-associated endocervical adenocarcinomas but had similar outcomes to HPV-independent gastric-type adenocarcinoma. However, these results were dependent on the stage of the cancer.

Possible Complications When Diagnosed with Clear Cell Carcinoma of the Cervix

Research shows that clear cell carcinoma, a type of tumor, is often linked with the invasion of lymphovascular spaces and the spread of cancer to lymph nodes. In fact, up to 25% of cases noted involvement of lymph nodes in the pelvis. Some researchers found that, in 31% of cases, the lymphovascular system was invaded and, in 24.1% of cases, lymph nodes were affected. Furthermore, 10.3% of cases were linked with spread (metastases) in the abdomen and pelvis, 32.8% experienced a return (recurrence) of disease, and 19% of patients passed away due to the disease.

The sites where the disease commonly comes back include:

  • Lung
  • Liver
  • Bone
  • Brain
  • Peritoneum (lining of the abdomen)
  • Retroperitoneum (area at the back of the abdomen)
  • Mediastinal lymph nodes (in the chest)
  • Vagina
  • Sigmoid colon (part of the bowel)

Mostly, the reappearance of clear cell carcinoma of the uterine cervix is observed within 3 years of the initial treatment. However, in a few cases, the recurrence has been noted as late as 8 years after the initial diagnosis. Factors that increase the risk of recurrence include the spread of disease to the tissues surrounding the uterus (parametrial extension), pelvic lymph nodes, and the edge of the vagina. For patients with these high-risk factors, a combination of chemotherapy and radiation (chemoradiation) is the preferred choice of treatment after surgery.

Preventing Clear Cell Carcinoma of the Cervix

Preventing and fighting against clear cell carcinoma of the cervix, a type of cervical cancer, mainly involves addressing changeable risk factors and encouraging regular health checks. It’s key that people are taught to steer clear of known cancer-causing substances, such as DES, when they are pregnant.

Healthcare professionals should make sure their patients know to seek advice at once if they start to experience any unusual uterine bleeding. Special attention should be given to bleeding that occurs before the first menstrual cycle, after menopause, or between menstrual periods. Such symptoms need quick medical attention. Doctors should be prepared to take a tissue sample from any abnormal areas found during a physical examination.

The healthcare team should provide patients with written information or refer them to useful websites, so they understand more about their condition. This includes knowledge about what causes it, its symptoms, how it is diagnosed and treated, possible side effects, and what can be expected in the future. It’s also helpful to provide resources on ways to cope, support groups, and other sources of information to keep patients informed, in control, and capable of making decisions about their treatment.

Frequently asked questions

Clear cell carcinoma of the cervix is a rare and invasive form of adenocarcinoma that makes up 4% of all adenocarcinomas in the cervix. It is primarily diagnosed through a detailed examination of tissue samples collected via biopsy and is characterized by clear or 'hobnail' cells under the microscope. Treatment options depend on the stage at diagnosis and the patient's preference to maintain fertility.

Clear cell carcinoma of the cervix accounts for about 3% of all cervical cancer cases.

Signs and symptoms of Clear Cell Carcinoma of the Cervix include: - Abnormal vaginal bleeding, which can occur after sexual intercourse or between periods. - Bleeding that does not respond well to hormonal treatments. - Cervical abnormality, often described as a 'fullness' of the cervix, which may be detected during a physical examination. - The tumor is usually not felt during a rectal examination.

Clear cell carcinoma of the cervix can be caused by exposure to a synthetic hormone known as DES in the womb, but it can also occur without any DES exposure. The exact cause and development process of these tumors is not fully understood, but there is a known link between cervical endometriosis and clear cell carcinoma.

Metastatic clear cell carcinoma, Arias-Stella reaction, Adenosis, Endometrioid adenocarcinomas, Gastric-type of endocervical adenocarcinoma, Cervical yolk sac tumors, Primary cervical alveolar soft part sarcomas, Benign cervical lesions, Cervicitis.

The types of tests that are needed for Clear Cell Carcinoma of the Cervix include: 1. Magnetic resonance imaging (MRI) scans: These are used to determine the stage of the tumor, assess the effectiveness of treatments, detect tumor recurrence, and identify potential complications. 2. Positron emission tomography/computed tomography (PET/CT) scans: This imaging method, using fluorodesoxyglucose, can be useful in examining cases where the cancer has spread to the lymph nodes in the pelvic cavity and retroperitoneum. 3. Cytology: While not as effective for diagnosing Clear Cell Carcinoma of the Cervix, cytology is still used to study cells and may be helpful in detecting other types of cervical cancer. These tests help doctors in planning treatments, predicting disease progression, and making surgical decisions for Clear Cell Carcinoma of the Cervix.

Clear Cell Carcinoma of the Cervix is treated similarly to cervical cancer. The treatment largely depends on the stage of the disease. For early-stage clear cell carcinoma, a common surgical treatment is a radical hysterectomy and a pelvic lymphadenectomy. This treatment may result in the patient being unable to have children. For later stages, external beam radiotherapy is the go-to treatment.

The text does not provide information about the specific side effects when treating Clear Cell Carcinoma of the Cervix.

The prognosis for Clear Cell Carcinoma of the Cervix depends on several factors, including the stage of the cancer, the size of the tumor, the growth pattern of the cancer cells, irregularities in the nucleus of the cells, mitotic activity, and how deep the cancer has invaded into the stroma. The most important factors affecting disease progression and overall survival are the FIGO stage and the status of the pelvic nodes. There is no existing data comparing the prognosis of Clear Cell Carcinoma to other subtypes of cervical adenocarcinoma.

You should see a gynecologist or an oncologist for Clear Cell Carcinoma of the Cervix.

Join our newsletter

Stay up to date with the latest news and promotions!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

We care about your data in our privacy policy.